Recently, Li Hong, Vice Chairman of the Tianjin Municipal People's Congress Standing Committee, and his delegation visited Laviana Pharma (Tianjin) Co., Ltd. for a special research study. Mr. Chen Wenthing, Chairman of Laviana Pharma, and Dr. Yang Guang, Chief Scientific Officer, attended and introduced the company's development situation. The purpose of this research is to further promote the implementation of the "Tianjin Municipal Regulations on the Protection of the Rights and Interests of Overseas Chinese," to legally protect the legitimate rights and interests of overseas Chinese, and to gain an in-depth understanding of the development status of overseas Chinese-funded enterprises, providing support and assistance for their development. Officials from the Municipal People's Congress Ethnic and Religious Affairs Committee, Municipal People's Congress representatives, Municipal Overseas Chinese Affairs Office, Municipal Overseas Chinese Federation, Municipal Overseas Chinese Chamb

In order to thoroughly implement the requirements for safety production deployment and to comprehensively enhance the safety awareness and emergency response capabilities of all employees, since June, Laviana Pharma has closely focused on the theme of "Everyone Talks About Safety, Everyone Knows Emergency Response". It has carefully planned and organized a series of diverse and content-rich activities for "Safety Production Month", laying a solid safety foundation for the company's stable operation.

On June 5. 2025. Chemspec Europe 2025. an important event in the European chemical and pharmaceutical sectors, successfully concluded in Cologne, Germany. Laviana Pharma showcased its innovative green synthesis technology and comprehensive CDMO solutions in Cologne, attracting potential clients and partners from Europe, North America, and the Asia-Pacific region for discussions, resulting in multiple cooperation intentions and injecting new momentum into the low-carbon transformation of the global pharmaceutical industry chain.

In order to further enhance employees' safety awareness and emergency response capabilities, and to strengthen their understanding of production quality management, the Laviana Pharma Cangzhou GMP production base recently conducted a specialized training activity on safety and quality. Through systematic and professional knowledge transfer, the training comprehensively improves employees' professional skills and risk prevention awareness, laying a solid foundation for the stable development of the enterprise.

Recently, Laviana Pharma (Cangzhou) Co., Ltd. actively responded to the Cangzhou Water Saving Office's campaign for the promotion of water conservation for 2025. During the "World Water Day" and "China Water Week," a unique water conservation promotional event was held at the Laviana Pharma Cangzhou GMP manufacturing base. This event showcased Laviana Pharma's commitment to water resource conservation and sustainable development.

On March 20. 2025 (local time), the 2025 DCAT Week concluded successfully in New York, USA. As a global CDMO service provider, Laviana Pharma once again became the focus of the industry with its outstanding technological strength and forward-looking strategic layout. This global event, hosted by the Drug, Chemical & Associated Technologies Association (DCAT), attracted many biopharmaceutical and upstream and downstream companies to discuss innovation and sustainable development in the industry chain.